Evidence map›Paper›PMID 38261919›Full record

ArticleiScience2024

COVID-19 test-to-stay program for K-12 schools: Opt-in versus opt-out consent model.

Anton Ivanov, Ujjal Kumar Mukherjee, Subhonmesh Bose, Sridhar Seshadri, Ronald Watkins, Albert Charles England, Jacqueline Suriano, Mehmet Eren Ahsen, Sebastian Souyris

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anton IvanovDepartment of Business Administration, University of Illinois at Urbana-Champaign, Champaign, IL 61821, USA.
Ujjal Kumar MukherjeeDepartment of Business Administration, University of Illinois at Urbana-Champaign, Champaign, IL 61821, USA.
Subhonmesh BoseElectrical and Computer Engineering, University of Illinois at Urbana-Champaign, Champaign, IL 61821, USA.
Sridhar SeshadriDepartment of Business Administration, University of Illinois at Urbana-Champaign, Champaign, IL 61821, USA.
Ronald WatkinsShield Illinois, University of Illinois System, Champaign, IL 61821, USA.
Albert Charles EnglandOSF HealthCare Heart of Mary Medical Center, Urbana, IL 61801, USA.
Jacqueline SurianoShield Illinois, University of Illinois System, Champaign, IL 61821, USA.
Mehmet Eren AhsenDepartment of Business Administration, University of Illinois at Urbana-Champaign, Champaign, IL 61821, USA.
Sebastian SouyrisLally School of Management, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Centers for Disease Control and Prevention promoted the Test-to-Stay (TTS) program to facilitate in-person instruction in K-12 schools during COVID-19. This program delineates guidelines for schools to regularly test students and staff to minimize risks of infection transmission. TTS enrollment can be implemented via two different consent models: opt-in, in which students do not test regularly by default, and the opposite, opt-out model. We study the impacts of the two enrollment approaches on testing and positivity rates with data from 259 schools in Illinois. Our results indicate that after controlling for other covariates, schools following the opt-out model are associated with 84% higher testing rate and 30% lower positivity rate. If all schools adopted the opt-out model, 20% of the total lost school days could have been saved. The lower positivity rate among the opt-out group is largely explained by the higher testing rate in these schools, a manifestation of status quo bias.

Indexed as

Research methodology social sciencesSocial sciencesSystem management

Identifiers

PMID38261919
PMCPMC10797182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.